← Back to Influence Map
Entity DossierOrganization
BRIDGEBIO PHARMA, INC.
CA · US
Biotech company
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$2,250,000
Connections
2
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
PHAPharmacy
$3.2MHCRHealth Issues
$230KMMMMedicare/Medicaid
$230KLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$3.2M
THORN RUN PARTNERS$230K
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Lobbied on | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $150,000 | Source |
| Retained | THORN RUN PARTNERS | Hired THORN RUN PARTNERS to lobby (1st Quarter (Jan 1 - Mar 31) 2024) | Source |